The 3BP2 Adapter Protein Is Required for Optimal B-Cell Activation and Thymus-Independent Type 2 Humoral Response

REFERENCES

• Cariappa, A., and S. Pillai. 2002. Antigen-dependent B-cell development. Curr. Opin. Immunol. 14:241–249.
   PubMed Web of Science ®Google Scholar
• Carter, R. H., D. A. Tuveson, D. J. Park, S. G. Rhee, and D. T. Fearon. 1991. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex. J. Immunol. 147:3663–3671.
   PubMed Web of Science ®Google Scholar
• Chalupny, N. J., A. Aruffo, J. M. Esselstyn, P. Y. Chan, J. Bajorath, J. Blake, L. K. Gilliland, J. A. Ledbetter, and M. A. Tepper. 1995. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains. Eur. J. Immunol. 25:2978–2984.
   PubMedGoogle Scholar
• Cicchetti, P., B. J. Mayer, G. Thiel, and D. Baltimore. 1992. Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257:803–806.
   PubMedGoogle Scholar
• Craxton, A., D. Magaletti, E. J. Ryan, and E. A. Clark. 2003. Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101:4464–4471.
   PubMed Web of Science ®Google Scholar
• Deckert, M., S. Tartare-Deckert, J. Hernandez, R. Rottapel, and A. Altman. 1998. Adaptor function for the Syk kinase-interacting protein 3BP2 in IL-2 gene activation. Immunity 9:595–605.
   PubMedGoogle Scholar
• de la Fuente, M. A., L. Kumar, B. Lu, and R. S. Geha. 2006. 3BP2 deficiency impairs the response of B cells, but not T cells, to antigen receptor ligation. Mol. Cell. Biol. 26:5214–5225.
   PubMedGoogle Scholar
• Dempsey, P. W., M. E. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348–350.
   PubMed Web of Science ®Google Scholar
• Fagarasan, S., and T. Honjo. 2000. T-independent immune response: new aspects of B cell biology. Science 290:89–92.
   PubMed Web of Science ®Google Scholar
• Fang, W., D. L. Mueller, C. A. Pennell, J. J. Rivard, Y. S. Li, R. R. Hardy, M. S. Schlissel, and T. W. Behrens. 1996. Frequent aberrant immunoglobulin gene rearrangements in pro-B cells revealed by a bcl-xL transgene. Immunity 4:291–299.
   PubMedGoogle Scholar
• Fearon, D. T., and M. C. Carroll. 2000. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18:393–422.
   PubMed Web of Science ®Google Scholar
• Foucault, I., S. Le Bras, C. Charvet, C. Moon, A. Altman, and M. Deckert. 2005. The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor. Blood 105:1106–1113.
   PubMedGoogle Scholar
• Fujimoto, M., J. C. Poe, P. J. Jansen, S. Sato, and T. F. Tedder. 1999. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J. Immunol. 162:7088–7094.
   PubMedGoogle Scholar
• Grossmann, M., L. A. O'Reilly, R. Gugasyan, A. Strasser, J. M. Adams, and S. Gerondakis. 2000. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J. 19:6351–6360.
   PubMedGoogle Scholar
• Grumont, R. J., I. J. Rourke, and S. Gerondakis. 1999. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13:400–411.
   PubMed Web of Science ®Google Scholar
• Grynkiewicz, G., M. Poenie, and R. Y. Tsien. 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440–3450.
   PubMed Web of Science ®Google Scholar
• Jevremovic, D., D. D. Billadeau, R. A. Schoon, C. J. Dick, and P. J. Leibson. 2001. Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2. J. Immunol. 166:7219–7228.
   PubMedGoogle Scholar
• Jumaa, H., B. Wollscheid, M. Mitterer, J. Wienands, M. Reth, and P. J. Nielsen. 1999. Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65. Immunity 11:547–554.
   PubMedGoogle Scholar
• Kendrick, T. S., R. J. Lipscombe, O. Rausch, S. E. Nicholson, J. E. Layton, L. C. Goldie-Cregan, and M. A. Bogoyevitch. 2004. Contribution of the membrane-distal tyrosine in intracellular signaling by the granulocyte colony-stimulating factor receptor. J. Biol. Chem. 279:326–340.
   PubMedGoogle Scholar
• Khan, W. N., F. W. Alt, R. M. Gerstein, B. A. Malynn, I. Larsson, G. Rathbun, L. Davidson, S. Muller, A. B. Kantor, L. A. Herzenberg, et al. 1995. Defective B cell development and function in Btk-deficient mice. Immunity 3:283–299.
   PubMed Web of Science ®Google Scholar
• Kraal, G., K. Schornagel, P. R. Streeter, B. Holzmann, and E. C. Butcher. 1995. Expression of the mucosal vascular addressin, MAdCAM-1, on sinus-lining cells in the spleen. Am. J. Pathol. 147:763–771.
   PubMed Web of Science ®Google Scholar
• Lane, P. J., D. Gray, S. Oldfield, and I. C. MacLennan. 1986. Differences in the recruitment of virgin B cells into antibody responses to thymus-dependent and thymus-independent type-2 antigens. Eur. J. Immunol. 16:1569–1575.
   PubMed Web of Science ®Google Scholar
• Li, X., D. Sandoval, L. Freeberg, and R. H. Carter. 1997. Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig. J. Immunol. 158:5649–5657.
   PubMedGoogle Scholar
• Litinskiy, M. B., B. Nardelli, D. M. Hilbert, B. He, A. Schaffer, P. Casali, and A. Cerutti. 2002. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3:822–829.
   PubMed Web of Science ®Google Scholar
• Martin, F., and J. F. Kearney. 2000. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a “natural immune memory.” Immunol. Rev. 175:70–79.
   PubMed Web of Science ®Google Scholar
• Matsumoto, A. K., D. R. Martin, R. H. Carter, L. B. Klickstein, J. M. Ahearn, and D. T. Fearon. 1993. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J. Exp. Med. 178:1407–1417.
   PubMedGoogle Scholar
• Mond, J. J., A. Lees, and C. M. Snapper. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13:655–692.
   PubMed Web of Science ®Google Scholar
• Nagar, B., O. Hantschel, M. A. Young, K. Scheffzek, D. Veach, W. Bornmann, B. Clarkson, G. Superti-Furga, and J. Kuriyan. 2003. Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell 112:859–871.
   PubMed Web of Science ®Google Scholar
• Oliver, A. M., F. Martin, G. L. Gartland, R. H. Carter, and J. F. Kearney. 1997. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 27:2366–2374.
   PubMedGoogle Scholar
• Opferman, J. T., A. Letai, C. Beard, M. D. Sorcinelli, C. C. Ong, and S. J. Korsmeyer. 2003. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 426:671–676.
   PubMed Web of Science ®Google Scholar
• O'Rourke, L. M., R. Tooze, M. Turner, D. M. Sandoval, R. H. Carter, V. L. Tybulewicz, and D. T. Fearon. 1998. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity 8:635–645.
   PubMedGoogle Scholar
• Pillai, S., A. Cariappa, and S. T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23:161–196.
   PubMed Web of Science ®Google Scholar
• Ren, R., B. J. Mayer, P. Cicchetti, and D. Baltimore. 1993. Identification of a ten-amino acid proline-rich SH3 binding site. Science 259:1157–1161.
   PubMed Web of Science ®Google Scholar
• Saborit-Villarroya, I., J. M. Del Valle, X. Romero, E. Esplugues, P. Lauzurica, P. Engel, and M. Martin. 2005. The adaptor protein 3BP2 binds human CD244 and links this receptor to Vav signaling, ERK activation, and NK cell killing. J. Immunol. 175:4226–4235.
   PubMedGoogle Scholar
• Sada, K., S. M. Miah, K. Maeno, S. Kyo, X. Qu, and H. Yamamura. 2002. Regulation of FcepsilonRI-mediated degranulation by an adaptor protein 3BP2 in rat basophilic leukemia RBL-2H3 cells. Blood 100:2138–2144.
   PubMedGoogle Scholar
• Saito, K., K. F. Tolias, A. Saci, H. B. Koon, L. A. Humphries, A. Scharenberg, D. J. Rawlings, J. P. Kinet, and C. L. Carpenter. 2003. BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity. Immunity 19:669–678.
   PubMed Web of Science ®Google Scholar
• Saito, T., S. Chiba, M. Ichikawa, A. Kunisato, T. Asai, K. Shimizu, T. Yamaguchi, G. Yamamoto, S. Seo, K. Kumano, E. Nakagami-Yamaguchi, Y. Hamada, S. Aizawa, and H. Hirai. 2003. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 18:675–685.
   PubMed Web of Science ®Google Scholar
• Schiemann, B., J. L. Gommerman, K. Vora, T. G. Cachero, S. Shulga-Morskaya, M. Dobles, E. Frew, and M. L. Scott. 2001. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293:2111–2114.
   PubMed Web of Science ®Google Scholar
• Schneider, P., H. Takatsuka, A. Wilson, F. Mackay, A. Tardivel, S. Lens, T. G. Cachero, D. Finke, F. Beermann, and J. Tschopp. 2001. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J. Exp. Med. 194:1691–1697.
   PubMed Web of Science ®Google Scholar
• Songyang, Z., S. E. Shoelson, J. McGlade, P. Olivier, T. Pawson, X. R. Bustelo, M. Barbacid, H. Sabe, H. Hanafusa, T. Yi, et al. 1994. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell. Biol. 14:2777–2785.
   PubMed Web of Science ®Google Scholar
• Southgate, J., U. Sarma, J. V. Townend, J. Barron, and A. M. Flanagan. 1998. Study of the cell biology and biochemistry of cherubism. J. Clin. Pathol. 51:831–837.
   PubMedGoogle Scholar
• Su, A. I., T. Wiltshire, S. Batalov, H. Lapp, K. A. Ching, D. Block, J. Zhang, R. Soden, M. Hayakawa, G. Kreiman, M. P. Cooke, J. R. Walker, and J. B. Hogenesch. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA. 101:6062–6067.
   PubMed Web of Science ®Google Scholar
• Tedder, T. F., and C. M. Isaacs. 1989. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. J. Immunol. 143:712–717.
   PubMed Web of Science ®Google Scholar
• Tuveson, D. A., R. H. Carter, S. P. Soltoff, and D. T. Fearon. 1993. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260:986–989.
   PubMed Web of Science ®Google Scholar
• Ueki, Y., V. Tiziani, C. Santanna, N. Fukai, C. Maulik, J. Garfinkle, C. Ninomiya, C. doAmaral, H. Peters, M. Habal, L. Rhee-Morris, J. B. Doss, S. Kreiborg, B. R. Olsen, and E. Reichenberger. 2001. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat. Genet. 28:125–126.
   PubMed Web of Science ®Google Scholar
• van Noesel, C. J., A. C. Lankester, G. M. van Schijndel, and R. A. van Lier. 1993. The CR2/CD19 complex on human B cells contains the src-family kinase Lyn. Int. Immunol. 5:699–705.
   PubMed Web of Science ®Google Scholar
• Vigorito, E., E. Clayton, and M. Turner. 2004. BCR activation of PI3K is Vav-independent in murine B cells. Biochem. Soc. Trans. 32:781–784.
   PubMedGoogle Scholar
• von Bulow, G. U., J. M. van Deursen, and R. J. Bram. 2001. Regulation of the T-independent humoral response by TACI. Immunity 14:573–582.
   PubMed Web of Science ®Google Scholar
• Wang, Y., S. R. Brooks, X. Li, A. N. Anzelon, R. C. Rickert, and R. H. Carter. 2002. The physiologic role of CD19 cytoplasmic tyrosines. Immunity 17:501–514.
   PubMed Web of Science ®Google Scholar
• Woodring, P. J., T. Hunter, and J. Y. Wang. 2005. Mitotic phosphorylation rescues Abl from F-actin-mediated inhibition. J. Biol. Chem. 280:10318–10325.
   PubMedGoogle Scholar
• Zipfel, P. A., M. Grove, K. Blackburn, M. Fujimoto, T. F. Tedder, and A. M. Pendergast. 2000. The c-Abl tyrosine kinase is regulated downstream of the B cell antigen receptor and interacts with CD19. J. Immunol. 165:6872–6879.
   PubMedGoogle Scholar